From Guidelines to Practice: Comparing New Guideline Directions in Global Atrial Fibrillation Management

Description

This session offers a comparison of the latest clinical guidelines for atrial fibrillation (AF), including the 2023 AHA/ACC/HRS and the 2024 ESC Guidelines. Experts will highlight key updates, discuss differences in recommendations, and address the current gaps in evidence while exploring practical applications of guideline recommendations for AF management.

Learning Objectives

Identify and understand the key updates in the 2023 AHA/ACC/HRS and 2024 ESC AF guidelines, including recommendations for stroke prevention, rhythm and rate control, and patient-centered care.
Explore the role of lifestyle and risk factor modifications in AF management and its impact on patient outcomes.
Apply updated clinical guidance for AF ablation in real-world practice through case-based learning, comparing insights from recent guidelines and consensus statements to inform individualized patient care.

Session Chair(s)

Deepak Bhakta, MBA, MD
Yong-Mei Cha, MD

Presentation

What’s New in the 2023 AHA/ACC/HRS AF Guideline?
Presenter(s): Jose A. Joglar, MD

What’s New in the 2024 ESC AF Guideline?
Presenter(s): Tom De Potter, MD, PhD

Lifestyle and Risk Factor Modification in AF Management
Presenter(s): Megan M. Streur, PhD, ARNP

Case-Based Approach to AF Ablation
Presenter(s): Edward P. Gerstenfeld, MD, MS

Gaps in Evidence and Our Understanding of AF
Presenter(s): Rakesh Gopinathannair, MA, MD

Disclosures

Jose Joglar:

Nothing Relevant to Disclose

Tom De Potter:

Adagio Medical (Stock Options – Privately Held (including start-up companies) - Research)

Megan Streur:

Nothing Relevant to Disclose

Edward Gerstenfeld:

Medtronic (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott Medical (DSMB member - Consulting)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott Medical (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Varian Medical Systems (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)

Rakesh Gopinathannair:

AltaThera Pharmaceuticals (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Supraventricular Tachyarrhythmias
-- AFib and Flutter
-- 116. Know the indications, targets, pharmacological and nonpharmacologic options for rate control.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered